Acadia Pharmaceuticals Inc. · 1 day ago
Manager, FP&A - Commercial
Acadia Pharmaceuticals is committed to innovation for underserved neurological and rare disease communities. The Manager, FP&A - Commercial will serve as the primary finance business partner to the Commercial organization, responsible for delivering reporting and analytics to drive financial decision-making.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Manage Commercial forecasts for assigned brands and functions, including revenue drivers, GTN, managed spend, and headcount, partnering closely with Brand, Sales, Marketing, Market Access, and Commercial Operations
Act as a finance business partner to Brand and Commercial stakeholders, providing timely analysis and financial support to inform day-to-day and near-term decision-making
Prepare and deliver routine Commercial FP&A reporting, including actuals vs. forecast vs. plan, variance analysis, and commentary on key drivers, risks, and opportunities
Execute recurring Commercial planning processes, including rolling forecasts, Annual Operating Plans (AOP), and Long-Range Plans (LRP), ensuring accuracy, consistency, and alignment with brand plans
Develop financial analyses and business cases to support brand initiatives, incremental spend requests, promotional mix decisions, and field force or launch-related investments
Partner cross-functionally and with FP&A peers to consolidate total brand spend across matrixed Medical Affairs and G&A functions, ensuring accurate financial forecasts and reporting
Monitor commercial spend and vendor activity, identifying risks, savings opportunities, and timing shifts, and communicating impacts to Commercial and Finance leadership
Collaborate with Accounting and Finance Operations to support accurate accruals, expense recognition, and compliance with company policies
Utilize corporate financial systems and planning tools to perform forecasting, reporting, and ad-hoc analysis while supporting ongoing process improvements
Qualification
Required
Bachelor's degree in Accounting, Finance, or Economics
5+ years of experience in a financial planning and analysis role, business partnering or other finance area, ideally with experience in healthcare
Experience working closely with the Commercial organizations
High level of intellectual curiosity, with ability to work independently and solve complex problems
Excellent financial analysis skills and ability to translate analyses into sound strategic recommendations
Ability to think strategically and communicate effectively across all levels of the organization
Proven track record of reliable, detailed and accurate work product
Ability to work in a results-oriented, project-driven, real-time team environment, prioritize projects and deliver quality results within tight time constraints
Excellent written and verbal communication, presentation skills, and MS Office proficiency
Working knowledge of Generally Accepted Accounting Principles (US GAAP)
Advanced knowledge of financial reporting, forecasting and planning applications (NetSuite a plus)
Preferred
MBA preferred
An equivalent combination of relevant education and applicable job experience may be considered
Benefits
Medical, dental, and vision insurance
Employer-paid life, disability, business travel and EAP coverage
401(k) Plan with a fully vested company match 1:1 up to 5%
Employee Stock Purchase Plan with a 2-year purchase price lock-in
15+ vacation days
13 -15 paid holidays, including office closure between December 24th and January 1st
10 days of paid sick time
Paid parental leave benefit
Tuition assistance
Company
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
Funding
Current Stage
Public CompanyTotal Funding
$811.73MKey Investors
National Institute of Neurological Disorders and StrokeOxford Bioscience PartnersNational Institute of Mental Health
2019-09-17Post Ipo Equity· $287.5M
2018-11-30Post Ipo Equity· $316.25M
2013-01-02Post Ipo Equity· $86.39M
Recent News
2025-11-20
Company data provided by crunchbase